{
    "organizations": [],
    "uuid": "42fad78e05b19d740667daa53413db391b0fe411",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cancer-genetics-reports-q1-loss-pe/brief-cancer-genetics-reports-q1-loss-per-share-0-16-idUSASC0A289",
    "ord_in_thread": 0,
    "title": "BRIEF-Cancer Genetics Reports Q1 Loss Per Share $0.16",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Cancer Genetics Inc:\n* CANCER GENETICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES STRATEGIC BUSINESS UPDATES\n* Q1 LOSS PER SHARE $0.16 * Q1 REVENUE ROSE 10 PERCENT TO $7.7 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-15T19:19:00.000+03:00",
    "crawled": "2018-05-16T18:44:35.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "cancer",
        "genetics",
        "inc",
        "cancer",
        "genetics",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "strategic",
        "business",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "revenue",
        "rose",
        "percent",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}